Variables | Univariate analysis | ||
---|---|---|---|
Odds ratio | 95% CI | p-value | |
Patient demographic | |||
Age ≥ 65 years | 1.01 | 0.99–1.03 | 0.319 |
Male | 0.93 | 0.53–1.62 | 0.796 |
Malignancy profile | |||
Solid tumor | 1.04 | 0.52–2.08 | 0.911 |
Vital signs | |||
Pulse oximetry ≤ 90% | 2.37 | 1.32–4.28 | 0.004 |
RR ≥ 30 per minute | 2.70 | 1.50–4.86 | 0.001 |
SBP < 90 mmHg or DBP ≤ 60 mmHg | 0.78 | 0.41–1.48 | 0.449 |
PR ≥ 125 per minute | 1.19 | 0.66–2.16 | 0.571 |
BT < 35 or ≥ 40 Celsius | 0.59 | 0.07–5.40 | 0.643 |
PPS within 24 h of admission (Compared to PPS ≥ 60) | |||
PPS 40–50 | 3.52 | 1.77-7.00 | < 0.001 |
PPS ≤ 30 | 9.51 | 4.17–21.69 | < 0.001 |
Laboratory | |||
Hematocrit > 30% | 0.91 | 0.52–1.59 | 0.745 |
WBC < 4 × 10^3 or > 20 × 10^3 per cubic mm | 1.40 | 0.80–2.46 | 0.241 |
Percentage of lymphocytes ≤ 8.0% | 2.34 | 1.33–4.15 | 0.003 |
Sodium < 130 mEq/L | 1.16 | 0.63–2.12 | 0.636 |
Serum glucose ≥ 250 mg/dL | 1.34 | 0.71–2.52 | 0.369 |
BUN ≥ 20 mg/dL | 2.22 | 1.14–4.32 | 0.020 |
Co-morbidity | |||
Congestive heart failurea | - | - | - |
Cerebrovascular disease | 0.96 | 0.18–5.07 | 0.962 |
Renal disease | 0.54 | 0.15–1.94 | 0.341 |
Liver disease | 0.80 | 0.16–4.04 | 0.782 |
Treatment history | |||
Received chemotherapy within 4 weeks | 0.39 | 0.17–0.88 | 0.023 |
Received chest radiation therapy within 4 weeks | - | - | - |